NO178133C - Fremgangsmåte for fremstilling av en farmasöytisk doseringsform med kontrollert frigivelse, som har minst tre overtrekk - Google Patents

Fremgangsmåte for fremstilling av en farmasöytisk doseringsform med kontrollert frigivelse, som har minst tre overtrekk

Info

Publication number
NO178133C
NO178133C NO893677A NO893677A NO178133C NO 178133 C NO178133 C NO 178133C NO 893677 A NO893677 A NO 893677A NO 893677 A NO893677 A NO 893677A NO 178133 C NO178133 C NO 178133C
Authority
NO
Norway
Prior art keywords
controlled release
active principle
preparation
dosage form
coatings
Prior art date
Application number
NO893677A
Other languages
English (en)
Norwegian (no)
Other versions
NO893677D0 (no
NO893677L (no
NO178133B (no
Inventor
Gian Carlo Santus
Roberto Golzi
Original Assignee
Recordati Chem Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Recordati Chem Pharm filed Critical Recordati Chem Pharm
Publication of NO893677D0 publication Critical patent/NO893677D0/no
Publication of NO893677L publication Critical patent/NO893677L/no
Publication of NO178133B publication Critical patent/NO178133B/no
Publication of NO178133C publication Critical patent/NO178133C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Management Or Editing Of Information On Record Carriers (AREA)
  • Indexing, Searching, Synchronizing, And The Amount Of Synchronization Travel Of Record Carriers (AREA)
NO893677A 1988-09-16 1989-09-14 Fremgangsmåte for fremstilling av en farmasöytisk doseringsform med kontrollert frigivelse, som har minst tre overtrekk NO178133C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8821961A IT1226940B (it) 1988-09-16 1988-09-16 Sistema terapeutico a rilascio controllato per formulazioni farmaceutiche liquide

Publications (4)

Publication Number Publication Date
NO893677D0 NO893677D0 (no) 1989-09-14
NO893677L NO893677L (no) 1990-03-19
NO178133B NO178133B (no) 1995-10-23
NO178133C true NO178133C (no) 1996-01-31

Family

ID=11189446

Family Applications (1)

Application Number Title Priority Date Filing Date
NO893677A NO178133C (no) 1988-09-16 1989-09-14 Fremgangsmåte for fremstilling av en farmasöytisk doseringsform med kontrollert frigivelse, som har minst tre overtrekk

Country Status (14)

Country Link
EP (1) EP0359195B1 (da)
JP (1) JP2719835B2 (da)
KR (1) KR0133531B1 (da)
CN (1) CN1043508C (da)
AT (1) ATE98485T1 (da)
AU (1) AU616562B2 (da)
CA (1) CA1338569C (da)
DE (1) DE68911439T2 (da)
DK (1) DK456789A (da)
ES (1) ES2060708T3 (da)
FI (1) FI103014B1 (da)
IL (1) IL91611A0 (da)
IT (1) IT1226940B (da)
NO (1) NO178133C (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1256651B (it) * 1992-12-11 1995-12-12 Giancarlo Santus Composizione farmaceutica a rilascio controllato in sospensione liquida
US5527545A (en) * 1989-09-18 1996-06-18 Recordati S.A. Chemical And Pharmaceutical Company Liquid-suspension controlled-release pharmaceutical composition
IT1270594B (it) * 1994-07-07 1997-05-07 Recordati Chem Pharm Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
EP0923312A1 (en) * 1996-04-29 1999-06-23 K.U. Leuven Research & Development Oral delivery form having a high absorption efficiency and method for making same
US6274592B1 (en) * 1997-02-04 2001-08-14 Senju Pharmaceutical Co., Ltd. Method for stabilizing arylcarboxylic acid, stabilizer thereof and aqueous solution containing stabilized arylcarboxylic acid
CA2261787C (en) * 1997-05-30 2006-11-14 Laboratorios Phoenix U.S.A., Inc. Multi-layered osmotic device
JP2000128774A (ja) * 1998-10-26 2000-05-09 Tanabe Seiyaku Co Ltd 薬物を含有する球形微粒子の製法
DE19856149C1 (de) * 1998-12-04 2000-06-15 Basf Ag Verfahren zur Herstellung von Agglomeraten mit Kern-Schale-Struktur
CA2395993A1 (en) * 1999-12-28 2001-07-05 Ajinomoto Co., Inc. Antidiabetic preparation for oral administration
EP1492511B3 (fr) 2002-04-09 2012-05-02 Flamel Technologies Formulation pharmaceutique orale sous forme de suspension aqueuse de microcapsules permettant la liberation modifiee de principe(s) actif(s)
KR20090088913A (ko) * 2006-11-21 2009-08-20 맥네일-피피씨, 인코포레이티드 개질된 방출형 진통 현탁제

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2921883A (en) * 1957-05-03 1960-01-19 Smith Kline French Lab Novel coating material for medicaments
NZ210785A (en) * 1984-01-13 1987-11-27 Battelle Development Corp Liquid dispersions of layered controlled release dosage forms
WO1987007833A1 (en) * 1986-06-20 1987-12-30 Shacknai Jonah Oral sustained release medicament
IT1200217B (it) * 1986-09-30 1989-01-05 Valducci Roberto Membrana per uso farmaceutico ed industriale

Also Published As

Publication number Publication date
EP0359195B1 (en) 1993-12-15
AU616562B2 (en) 1991-10-31
KR900004328A (ko) 1990-04-12
FI103014B (fi) 1999-04-15
JP2719835B2 (ja) 1998-02-25
NO893677D0 (no) 1989-09-14
DK456789D0 (da) 1989-09-15
EP0359195A2 (en) 1990-03-21
FI103014B1 (fi) 1999-04-15
CN1043508C (zh) 1999-06-02
FI894272L (fi) 1990-03-17
ES2060708T3 (es) 1994-12-01
DE68911439D1 (de) 1994-01-27
NO893677L (no) 1990-03-19
ATE98485T1 (de) 1994-01-15
IT1226940B (it) 1991-02-22
IL91611A0 (en) 1990-04-29
DE68911439T2 (de) 1994-04-14
IT8821961A0 (it) 1988-09-16
CA1338569C (en) 1996-09-03
FI894272A0 (fi) 1989-09-11
CN1041104A (zh) 1990-04-11
JPH02121918A (ja) 1990-05-09
EP0359195A3 (en) 1991-04-24
KR0133531B1 (ko) 1998-04-23
NO178133B (no) 1995-10-23
AU4135789A (en) 1990-03-22
DK456789A (da) 1990-03-17

Similar Documents

Publication Publication Date Title
NO178133C (no) Fremgangsmåte for fremstilling av en farmasöytisk doseringsform med kontrollert frigivelse, som har minst tre overtrekk
Hall et al. Evidence that c-src is involved in the process of osteoclastic bone resorption
IE811680L (en) Tri-substituted imidazole derivatives
DE69431089D1 (de) Formulierungen mit kontrollierter Abgabe überzogen mit wässrigen Dispersionen von Ethylcellulose
EP0638560A4 (en) MEDICINE FOR OSTEOPOROSIS AND DIAZEPINE COMPOUND *.
ATA249588A (de) 4h-1-benzopyran-4-on-derivate oder deren salze, verfahren zur herstellung derselben und pharmazeutische zusammensetzung, welche dieselben als wirkstoff enthalten
DE69206214D1 (de) Neue Arylethylaminderivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen.
NO169996C (no) Fremgangsmaate ved fremstilling av et farmasoeytisk preparat med kontrollert utskillelse av virkestoff
LV12399A (lv) Uzlabotas vienreiz diena lietojamas pulsejosas miniciklina mogades sistemas
PT824344E (pt) Composicao de revestimento em po para revestimento electrostatico de substratos farmaceuticos
DK0580078T3 (da) Polyvinylamin-derivater med hydrofyle centrer,fremgangsmåde til deres fremstilling samt anvendelse af forbindelserne som lægemidler, bærere af aktive stoffer og næringsmiddelhjælpestof.
Junquero et al. Inhibition of cytokine‐induced nitric oxide production by transforming growth factor‐beta 1 in human smooth muscle cells.
KR890700344A (ko) 약학 제제
KR940006985A (ko) 치환된 사이클로헥산 유도체, 이의 제조방법 및 질환을 치료하기 위한 이의 용도
Packard et al. Effect of posttraining injections of glucose on acquisition of two appetitive learning tasks
ATE16394T1 (de) Stabile salze von s-adenosinylmethionin, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen welche als aktive substanz diese derivate enthalten.
RU94040886A (ru) Применение производных мелатонина для лечения нарушений сна, фармацевтическая композиция
Liu et al. Mineralized nanofibrous scaffold promotes phenamil‐induced osteoblastic differentiation while mitigating adipogenic differentiation
EP0546846A1 (en) Programmed-release pharmaceutical compositions
AR004196A1 (es) Un metodo a alta velocidad para preparar granulos esfericos que comprende un medicamento para uso farmaceutico, granulos obtenibles mediante este metodoy una bolsita que contiene dichos granulos
DE68900903D1 (de) Diltiazem-mikrokugeln, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen mit gesteuerter abgabe.
DE59611212D1 (de) Transdermales therapeutisches system zur verabreichung von (s)-3-methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazol oder einem seiner pharmazeutisch akzeptablen salze
Bick et al. Piracetam: a new platelet suppressing drug
Bonne et al. Potentiation Of Anti-Aggregating Prostaglandins By Ticlopidin
Krechniak et al. Effect of selected pyrethroids on cholinesterase activity in rat.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN MARCH 2003